NCT00190424View on ClinicalTrials.gov

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2010

Conditions
Glioblastoma
Interventions
DRUG

CpG-ODN

Trial Locations (2)

75013

Hopital Salpetriere, Paris

75018

Hopital Lariboisiere, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00190424 - Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma | Biotech Hunter | Biotech Hunter